Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Go back to Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
(NASDAQ: GENB) Delayed: 13.07 +0.17 (1.32%)
Previous Close $12.90    52 Week High $ 
Open $13.04    52 Week Low $ 
Day High $13.21    P/E N/A 
Day Low $12.80    EPS $ 
Volume 160,616